Meanwhile, FOXA1, closely linked to tumor chemoresistance, enhances EMT, metastasis, and chemoresistance in docetaxel-resistant LAD cells [16], and its upregulation in endocrine therapy-resistant breast cancer promotes drug resistance via transcriptional regulation of downstream genes [17]. The gene discussed is FOXA1; the disease is breast carcinoma.